Back to today’s briefing

Story perspectives

Alibaba's PANDA AI Detects Pancreatic Cancer with 93% Accuracy

1/4/2026

47 9

Summary

Story summary

Alibaba's PANDA AI detects pancreatic cancer at early stages by analyzing low-radiation CT scans in China.
In Ningbo clinical trials, PANDA identified 24 pancreatic cases, 14 at early stages.
A 2023 study reported 93% accuracy identifying pancreatic lesions.
The system generated 1,400 alerts, with only 300 requiring further testing.
The U.S. Food and Drug Administration granted PANDA breakthrough device status.

1 of 1

Story summary

Alibaba's PANDA AI detects pancreatic cancer at early stages by analyzing low-radiation CT scans in China.
In Ningbo clinical trials, PANDA identified 24 pancreatic cases, 14 at early stages.
A 2023 study reported 93% accuracy identifying pancreatic lesions.
The system generated 1,400 alerts, with only 300 requiring further testing.
The U.S. Food and Drug Administration granted PANDA breakthrough device status.